Each filer's latest filing for 03969K108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 14.1% |
10/5/2026
Event 9/30/2026
|
||
|
Frazier Life Sciences VIII, L.P.
13D/A
|
7.5% |
8/20/2025
Event 8/18/2025
|
||
| Frazier Life Sciences VIII, L.P. | 7.3% | |||
| FHM Life Sciences VIII, L.P. | 7.4% | |||
| FHM Life Sciences VIII, L.L.C. | 7.4% | |||
| Frazier Life Sciences X, L.P. | 0% | |||
| FHMLS X, L.P. | 0% | |||
| FHMLS X, L.L.C. | 0% | |||
| Frazier Life Sciences Public Fund, L.P. | 0.6% | |||
| FHMLSP, L.P. | 0.6% | |||
| FHMLSP, L.L.C. | 0.6% | |||
| Frazier Life Sciences Public Overage Fund, L.P. | 0.2% | |||
| FHMLSP Overage, L.P. | 0.2% | |||
| FHMLSP Overage, L.L.C. | 0.2% | |||
| Frazier Life Sciences XI, L.P. | 0.1% | |||
| FHMLS XI, L.P. | 0.1% | |||
| FHMLS XI, L.L.C. | 0.1% | |||
| Frazier Life Sciences XII, L.P. | 0.1% | |||
| FHMLS XII, L.P. | 0.1% | |||
| FHMLS XII, L.L.C. | 0.1% | |||
| James N. Topper | 7.4% | |||
| Patrick J. Heron | 7.5% | |||
|
Rubric Capital Management LP
13G/A
|
6.8% |
2/13/2026
Event 12/31/2025
|
||
| Rubric Capital Management LP | 6.8% | |||
| David Rosen | 6.8% | |||
| State Street Corp 13G | 6.1% |
11/10/2026
Event 9/30/2026
|
||
|
Polar Capital Holdings Plc
13G
|
5.3% |
8/14/2026
Event 6/30/2026
|
||
| Polar Capital Holdings Plc | 5.3% | |||
| Polar Capital LLP | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
| Prudential Financial Inc 13G/A | 4.3% |
5/8/2026
Event 3/31/2026
|
||
| Jennison Associates LLC 13G/A | 4.0% |
5/6/2026
Event 3/31/2026
|
||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 297 | 149 M | $3.96B |
| 2026 Q2 | 273 | 131 M | $3.45B |
| 2026 Q1 | 273 | 132 M | $3.12B |
| 2025 Q4 | 287 | 129 M | $3.75B |
| 2025 Q3 | 242 | 126 M | $2.37B |
| 2025 Q2 | 232 | 127 M | $1.78B |
| 2025 Q1 | 244 | 126 M | $1.97B |
| 2024 Q4 | 211 | 129 M | $1.79B |
| 2024 Q3 | 190 | 129 M | $1.20B |
| 2024 Q2 | 190 | 127 M | $1.18B |
| 2024 Q1 | 169 | 125 M | $1.24B |
| 2023 Q4 | 135 | 101 M | $327M |
| 2023 Q3 | 137 | 67.1 M | $357M |
| 2023 Q2 | 142 | 71.8 M | $684M |
| 2023 Q1 | 147 | 71.6 M | $797M |
| 2022 Q4 | 145 | 66.1 M | $980M |
| 2022 Q3 | 142 | 59.4 M | $1.13B |
| 2022 Q2 | 118 | 49.1 M | $1.05B |
| 2022 Q1 | 111 | 48.3 M | $930M |
| 2021 Q4 | 95 | 46.4 M | $962M |
| 2021 Q3 | 104 | 45.7 M | $1.09B |
| 2021 Q2 | 104 | 45.5 M | $1.24B |
| 2021 Q1 | 96 | 46.8 M | $1.35B |
| 2020 Q4 | 79 | 41.0 M | $1.15B |
| 2020 Q3 | 64 | 34.8 M | $1.02B |
| 2020 Q2 | 57 | 33.8 M | $1.02B |
| 2020 Q1 | 51 | 32.7 M | $974M |